Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia

被引:35
作者
Kojima, Ariko
Ohno-Matsui, Kyoko
Teramukai, Satoshi
Ishihara, Yoko
Shimada, Noriaki
Yoshida, Takeshi
Sugamoto, Yoshiharu
Tokoro, Takashi
Mochizuki, Manabu
机构
[1] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, Tokyo 1138519, Japan
[2] Kyoto Univ Hosp, Dept Clin Trial Design & Management, Translat Res Ctr, Sakyo Ku, Kyoto, Japan
[3] Kurume Univ, Sch Med, Dept Publ Hlth, Fukuoka, Japan
基金
日本学术振兴会;
关键词
pathologic myopia; choroidal neovascularization; visual outcome; multiple regression analysis;
D O I
10.1007/s00417-006-0324-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To clarify prognostic factors of long-term visual outcome without treatment in patients with myopic choroidal neovascularization (CNV) and estimate a regression equation to predict visual acuity at 5 years after CNV onset. Methods: Fifty-four eyes of 54 consecutive patients with high myopia and subfoveal CNV who did not receive treatment were identified using clinical records from 1988 to 2004. Photodynamic therapy not approved for myopic CNV in Japan during this period. The association of best-corrected visual acuity (BCVA) at 5 years after CNV onset with patient age, refractive error, axial length, initial BCVA, myopic retinopathy grade, duration of persistent hemorrhage, CNV size at onset, and size of hemorrhage around the CNV was analyzed using Spearman's correlation and multiple linear regression analysis. Results: BCVA at 5 years after onset was significantly associated with patient age, CNV size, and initial BCVA (P < 0.05, Spearman's correlation). The regression equation estimating BCVA at 5 years after CNV onset was based on age and initial BCVA (R-2=0.43). When subjects were divided into groups according to age (< 40 and >= 40 years), CNV size, axial length and duration of persistent hemorrhage influenced BCVA at 5 years in patients under 40 years; while only initial BCVA was an influence in those at least 40 years old. Conclusions: We developed a linear predictive model to estimate BCVA at 5 years after onset of myopic CNV without treatment based on the identified prognostic factors. This information might be important for managing patients with myopic CNV.
引用
收藏
页码:1474 / 1479
页数:6
相关论文
共 23 条
[1]  
AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573
[2]   Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment [J].
Axer-Siegel, R ;
Ehrlich, R ;
Weinberger, D ;
Rosenblatt, F ;
Shani, L ;
Yassur, Y ;
Priel, E ;
Kramer, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (04) :602-607
[3]   Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia - 2-year results of a randomized clinical Trial - VIP report no. 3 [J].
Blinder, KJ ;
Blumenkranz, MS ;
Bressler, NM ;
Bressler, SB ;
Donati, G ;
Lewis, H ;
Lim, JI ;
Menchini, U ;
Miller, JW ;
Mones, JM ;
Potter, MJ ;
Pournaras, C ;
Reaves, A ;
Rosenfeld, P ;
Schachat, AP ;
Schmidt-Erfurth, U ;
Sickenberg, M ;
Singerman, LJ ;
Slakter, J ;
Strong, HA ;
Virgili, G ;
Williams, GA .
OPHTHALMOLOGY, 2003, 110 (04) :667-673
[4]   AXIAL LENGTH MEASUREMENTS AND FUNDUS CHANGES OF MYOPIC EYE [J].
CURTIN, BJ ;
KARLIN, DB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1971, 71 (01) :42-&
[5]  
CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P237
[6]   Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. [J].
Ergun, E ;
Heinzl, H ;
Stur, W .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (03) :434-438
[7]  
HAMPTON GR, 1983, OPHTHALMOLOGY, V90, P923
[8]   Characteristics of patients with a favorable natural course of myopic choroidal neovascularization [J].
Hayashi, K ;
Ohno-Matsui, K ;
Yoshida, T ;
Kobayashi, K ;
Kojima, A ;
Shimada, N ;
Yasuzumi, K ;
Futagami, S ;
Tokoro, T ;
Mochizuki, M .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (01) :13-19
[9]   PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION [J].
HOTCHKISS, ML ;
FINE, SL .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (02) :177-183
[10]  
Kayazawa F., 1983, J JPN OPHTHALMOL SOC, V87, P380